This phase II study demonstrated the efficacy of osimertinib 80 mg daily in patients with EGFR mutant NSCLC with leptomeningeal disease. The study designed included BICR using the RANO-LM assessment ...

Trump and Musk Hurl Insults as Policy Bill Spat Devolves Musk quickly responded on X. Musk then posted a poll on X. Trump responded on Truth Social. Trump threatened to cut Doge on Truth Social ...

Top stories from around the country.